Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Julie G. Allickson"'
Autor:
Paul R. Sanberg, David J. Eve, Alison E. Willing, Svitlana Garbuzova-Davis, Jun Tan, Cyndy D. Sanberg, Julie G. Allickson, L. Eduardo Cruz, Cesar V. Borlongan
Publikováno v:
Cell Transplantation, Vol 20 (2011)
Stem cell transplantation is a potentially important means of treatment for a number of disorders. Two different stem cell populations of interest are mononuclear umbilical cord blood cells and menstrual blood-derived stem cells. These cells are rela
Externí odkaz:
https://doaj.org/article/e643d6e45dd04e21be44a29dd1725ceb
Autor:
Amit N. Patel M.D, M.S, Eulsoon Park, Michael Kuzman, Federico Benetti, Francisco J. Silva, Julie G. Allickson PH.D
Publikováno v:
Cell Transplantation, Vol 17 (2008)
The stromal stem cell fraction of many tissues and organs has demonstrated to exhibit stem cell properties such as the capability of self-renewal and multipotency, allowing for multilineage differentiation. In this study, we characterize a population
Externí odkaz:
https://doaj.org/article/f8f81130fcc04f75b7cf5e6567dd34b7
Autor:
Julie G Allickson
Publikováno v:
Regenerative Medicine. 18:373-375
Julie G Allickson, PhD, is the Michael S and Mary Sue Shannon Family Director of Mayo Clinic’s Center for Regenerative Biotherapeutics at Mayo Clinic (Minnesota, Florida and Arizona) and the Otto Bremer Trust Director, Biomanufacturing and Product
Autor:
Wenchun Qu, Zhen Wang, Erica Engelberg-Cook, Dan Yan, Abu Bakar Siddik, Guojun Bu, Julie G Allickson, Eva Kubrova, Arnold I Caplan, Joshua M Hare, Camillo Ricordi, Carl J Pepine, Joanne Kurtzberg, Jorge M Pascual, Jorge M Mallea, Ricardo L Rodriguez, Tarek Nayfeh, Samer Saadi, Ravindra V Durvasula, Elaine M Richards, Keith March, Fred P Sanfilippo
Publikováno v:
Stem Cells Transl Med
MSC (a.k.a. mesenchymal stem cell or medicinal signaling cell) cell therapies show promise in decreasing mortality in acute respiratory distress syndrome (ARDS) and suggest benefits in treatment of COVID-19-related ARDS. We performed a meta-analysis
Autor:
John D. Jackson, Anthony Atala, Sunil George, Sang Jin Lee, Julie G. Allickson, Chao Zhang, Mehran Abolbashari, Tae-Hyoung Kim, In Kap Ko, James J. Yoo
Publikováno v:
Tissue Eng Part A
Kidney disease is a major medical problem globally. Chronic kidney disease (CKD) is a progressive loss of kidney function. It causes accumulation of waste and fluid in the body, eventually resulting in kidney failure as well as damaging other organs.
Publikováno v:
Cell Therapy ISBN: 9783030755355
Cell Therapy
Cell Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5274c59d5a41de5bb85c18e56b8bbf44
https://doi.org/10.1007/978-3-030-75537-9_33
https://doi.org/10.1007/978-3-030-75537-9_33
Autor:
Jorge M. Mallea, Samer Saadi, Ricardo L. Rodriguez, Elaine M. Richards, Guojun Bu, Erica Engelberg Cook, Wenchun Qu, Jorge M. Pascual, Tarek Nayfeh, Keith L. March, Julie G Allickson, Arnold I. Caplan, Abu Bakar Siddik, Joanne Kurtzberg, Joshua M. Hare, Carl J. Pepine, Eva Kubrova, Calillo Ricordi, Fred Sanfilippo, Zhen Wang
MSC (a.k.a. mesenchymal stem cell or medicinal signaling cell) cell therapies have shown promise in decreasing mortality in ARDS and suggest benefits in treatment of COVID-19 related ARDS. We performed a meta-analysis of published trials assessing th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1d4256eb43a119594bd64101bbf1d26
https://doi.org/10.1101/2021.10.05.21264559
https://doi.org/10.1101/2021.10.05.21264559
Autor:
Carl G. Simon, Julie G. Allickson, Sarah H. Beachy, Joshua G. Hunsberger, Claudia Zylberberg, Martha S. Lundberg
Publikováno v:
Current Stem Cell Reports. 5:162-172
The purpose of this review is to provide perspectives and resources for how cell and tissue manufacturing is being advanced by different stakeholders ranging from government to academia to even at a global scale. This perspective article illustrates
Autor:
Sasha Aleksic, Crystal Kraft, Kenneth Cornetta, Michael Scott, Dalia Alzebdeh, Harvey Brandwein, Dominic M. Clarke, Lexan Lhu, Yonatan Y. Lipsitz, Julie G. Allickson
Publikováno v:
Cytotherapy. 22(11)
A key hurdle to ensuring patient access to cell and gene therapies (CGTs) and continued growth of the industry is the management of raw materials. The combination of rapid growth, individual product and process complexity and limited industry-specifi
Autor:
Julie G. Allickson, Rafael G. Amado, Usman Azam, Frank Barry, Irene Aldecoa Bilbao, Gwendolyn K. Binder, Justin L. Black, Karin Blumer, Eugene P. Brandon, David A. Brindley, William Murray Burns, Francesca Capone, Guillaume Carmona, Michael Chaffman, William Chou, Zhanfeng Cui, Kevin A. D’Amour, Nathan J. Dowden, Bernd Eschgfaeller, Eric Faulkner, Maria Cristina Galli, Yoshio Goshima, Stephen J. Haggarty, Celine-Lea Halioua-Haubold, Kristen Harrington-Smith, Darren Hickerson, William Ho, Johan Hyllner, Natasha Iyer, Marieke Jansen, Etienne Jousseaume, Sven Kili, Antoinette F. Konski, Lawrence S. Lamb, Ching Lam, Jaeseung Lim, Chi Lo, Thomas Malcolm, Almudena Martinez-Fernandez, Todd Meinecke, Edward Meinert, Michael C. Milone, David A. Mitchell, Niraj Muni, Filomena Nappi, Neal H. Nathan, Emanuele Ostuni, Marianthi Papakosta, Simona Paratore, Vincenzo Lorenzo Pascali, Cameron D. Pernia, Benjamin Philipson, Fiona Phillips, James B. Phillips, Nasib Qureshi, Pietro Refolo, Moira Ringo, Matthew Robson, Crystal Ruff, Manuel Schmidt, Matthias Schroff, Michael J. Scott, Michaela Sharpe, Richard L. Sidman, John D. Sinden, Devyn M. Smith, Evan Y. Snyder, Sita Somara, Antonio Gioacchino Spagnolo, Daryl S. Spinner, Kanaka Sridharan, Michael Sullivan, Keith Thompson, Brian T.D. Tobe, Alain A. Vertès, Michael D. West, Cynthia Wilkins-Port, Burghardt Wittig, Aidong Yang, Jie Zhang, Mark C. Zimmerman
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::557c2ce10a659280ef90bb6618f8deb1
https://doi.org/10.1016/b978-0-12-812034-7.01002-5
https://doi.org/10.1016/b978-0-12-812034-7.01002-5